Search for information about a product,
therapeutic area or event

Media, investors, advocacy organizations and others, please contact us here.

Concomitant Sparsentan and Sodium-Glucose Cotransporter-2 Inhibitors in Adults With IgA Nephropathy in the Ongoing Phase 2 SPARTACUS Trial

Page 1 / 1 100%
Loading...